14. February 2017. | HEPATITIS C

Flawed patents on hepatitis C drugs latest to be challenged in global push for access

Five new challenges against patents on crucial new medicines to treat hepatitis C filed in India and Argentina are the latest in a global push to ensure access to affordable treatment. Read more